CXCR1 and viral infectious disease: These findings indicate that the CXCR2 blocking antibody is specific and suggest that genetic deletion of CXCR2 allows for compensatory mechanisms to emerge, such as utilization of CXCR1, that support PMN trafficking into the CNS in response to viral infection.